• Media type: E-Article
  • Title: Corrigendum: Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms
  • Contributor: Grünwald, Viktor; Powles, Thomas; Eto, Masatoshi; Kopyltsov, Evgeny; Rha, Sun Young; Porta, Camillo; Motzer, Robert; Hutson, Thomas E.; Méndez-Vidal, María José; Hong, Sung-Hoo; Winquist, Eric; Goh, Jeffrey C.; Maroto, Pablo; Buchler, Tomas; Takagi, Toshio; Burgents, Joseph E.; Perini, Rodolfo; He, Cixin; Okpara, Chinyere E.; McKenzie, Jodi; Choueiri, Toni K.
  • Published: Frontiers Media SA, 2024
  • Published in: Frontiers in Oncology, 13 (2024)
  • Language: Not determined
  • DOI: 10.3389/fonc.2023.1343027
  • ISSN: 2234-943X
  • Origination:
  • Footnote:
  • Access State: Open Access